Kwamesha Joseph

Researchers evaluated the safety and efficacy of naldemedine in patients with cancer who have poor performance status.

Researchers evaluated randomized controlled trial data on the efficacy of naldemedine in the treatment of opioid-induced constipation compared with placebo.

Researchers sought to improve identification of patients at risk for developing severe liver disease within 10 years.

Researchers sought to evaluate the effect of a patient’s sex on esophageal variceal bleeding outcomes in the United States.

Researchers sought to evaluate the incidence of gastroesophageal reflux disease following sleeve gastrectomy.

While food allergies may affect response to the medication, environmental allergies do not, the report says.

Tracy Frech, MD, provides a deeper insight into the compelling and clinically meaningful research in scleroderma, as presented at the ACR Convergence 2021.

While the causes of gender gaps are often complex and inextricably intertwined, a more in depth approach is needed to identify areas where immediate action can be taken to improve gender equity and diversity in gastroenterology.

Lynch syndrome is associated with 4 genetic variants that increase risk of CRC, thereby necessitating updated screening guidelines for these variants.

The gut microbiome is complex within irritable bowel disease (IBD), and its disruption may be a potential contributing factor in the pathogenesis of IBD.

The investigators aimed to report on early experience with OAGB compared to RYGB in terms of complication rates.

COVID-19 has systemic effects that include the gastrointestinal and pancreaticobiliary systems.

Can detection of irregular or spider vascularity on bile duct lesions during DSOC evaluations identify biliary neoplastic lesions? A new study examines this question.

This is the first study to report polymorphisms associated with long term response to anti-TNF treatment in pediatric patients with Crohn disease and ulcerative colitis.

Lower total hospitalization costs were identified in patients with IBS who used cannabis compared with patients who did not use cannabis.

Inflammatory bowel diseases are known to be associated with changes in the body’s defense.